SNT 6.67% 4.2¢ syntara limited

Ann: Pharmaxis Announces LOXL2 Program Phase 2 Ready, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,180 Posts.
    lightbulb Created with Sketch. 553

    Surprisingly the share price is still not moving much.

    Synairgen has only 15% interest in the LOXL2 and Pharmaxis has 85%, but yesterday Synairgen rose 18%.

    This company has cash, products already on the market, existing NASH deal with pharmas potentially bring in hundreds of millions of payment, and the MC is still at 100m.



 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
-0.003(6.67%)
Mkt cap ! $57.67M
Open High Low Value Volume
4.4¢ 4.5¢ 4.2¢ $37.11K 834.3K

Buyers (Bids)

No. Vol. Price($)
3 244513 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 220000 1
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.